查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1933297

全球女性健康医疗器材市场：市场规模、占有率、成长率、产业分析、依类型、应用和地区划分的考量因素以及未来预测（2026-2034）

Women's Health Devices Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 110 Pages | 商品交期: 请询问到货日

价格

女性健康医疗器材市场成长驱动因素

预计2025年全球女性健康医疗器材市场规模将达到603.9亿美元，从2026年的658.9亿美元增长至2034年的1415.7亿美元，在预测期内（2026-2034年）的复合年增长率（CAGR）为10.03%。北美地区将在2025年占45.70%的市场占有率，这主要得益于强劲的医疗保健支出、女性疾病的高发生率以及对技术先进的医疗器材日益增长的需求。

女性健康意识的提高、可支配收入的增加以及乳腺癌、卵巢癌等女性特有癌症和子宫肌瘤等疾病的发病率上升，是推动市场成长的关键因素。此外，年轻一代女性对先进健康监测和诊断设备的日益普及也促进了整体市场的扩张。

市场概览

女性健康领域的最新趋势促使各公司加大研发投入，推出涵盖诊断和监测设备以及治疗设备的新产品。例如，2021年12月，罗氏公司推出了用于晚期或转移性乳癌的cobas PIK3CA突变检测，提高了治疗的精准度，并促进了设备的普及。

由于就诊量减少和供应链中断，新冠疫情暂时阻碍了市场成长。 例如，Cooper Surgical公司报告称，其不孕症治疗业务在2020年的收入下降了11.2%。然而，在2021年，该市场復苏，销售额增长了39.2%，这得益于远距医疗和远距患者护理解决方案的日益普及。

市场驱动因素

女性健康问题意识的提升

医疗保健基础设施的改善以及美国食品药物管理局（FDA）女性健康计画等机构所进行的宣传活动，显着提高了早期检测和预防保健医疗器材的使用率。这些努力产生了显着影响，尤其是在年轻女性族群中，从而增加了对诊断、治疗和监测设备的需求。

女性疾病的成长趋势

由于子宫颈癌、乳癌和子宫肌瘤等女性特有的癌症和慢性疾病发生率不断上升，对专用医疗器械的需求也在增长。根据世界卫生组织2022年的报告，子宫颈癌是女性第四大常见癌症，2020年报告的新病例达60.4万例。这些趋势正在推动研发和产品上市，进一步促进市场成长。

限制因子

新兴地区意识水平低和医疗保健普及率低限制了市场成长。在印度和撒哈拉以南非洲等国家，文化禁忌、诊断意识低下以及先进设备的匮乏导致女性健康技术未被充分利用，从而抑制了整体市场扩张。

目录

第一章：引言

第二章：摘要整理

第三章：市场动态

  • 市场驱动因素
  • 市场限制因素
  • 市场机遇
  • 市场趋势

第四章：关键考虑因素

  • 各国及地区主要疾病盛行率（2025 年）
  • 概述：女性健康医疗器材市场的新兴公司与创新
  • 关键产业趋势：併购、合作等
  • 新冠疫情对女性健康医疗器材市场的影响

章节5 全球女性健康医疗器材市场分析：洞察与预测 (2021-2034)

  • 市场分析、洞察与预测：依应用领域划分
    • 一般健康与保健
    • 癌症及其他慢性疾病
    • 生殖健康
    • 孕期及哺乳期护理
    • 骨盆腔及子宫保健
    • 其他
  • 市场分析、洞察与预测：依最终用户划分
    • 医院及诊所
    • 家庭医疗保健
    • 其他
  • 市场分析、洞察与预测：依地区划分
    • 北美
    • 欧洲
    • 亚太地区
    • 世界其他地区 (ROW)

第六章 北美女性健康医疗器材市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 美国
    • 加拿大

第七章：欧洲女性健康医疗器材市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 英国
    • 德国
    • 法国
    • 西班牙
    • 义大利
    • 其他欧洲国家

第八章：亚太地区女性健康医疗器材市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 日本
    • 中国
    • 印度
    • 澳大利亚
    • 其他国家/地区亚太地区

第九章：世界其他地区（ROW）女性健康医疗器材市场分析：洞察与预测（2021-2034）

第十章：竞争分析

  • 全球市占率分析（2025）
  • 公司简介
  • Coloplast A/S
  • Hologic, Inc.
  • Boston Scientific Corporation
  • ALLERGAN(AbbVie, Inc.)
  • BD(Becton, Dickinson and Company)
  • F. Hoffmann-La Roche Ltd
  • CooperSurgical Inc.(The Cooper Companies, Inc.)
  • Caldera Medical
  • Reckitt Benckiser Group PLC
Product Code: FBI105732

Growth Factors of women's health devices Market

The global women's health devices market was valued at USD 60.39 billion in 2025 and is projected to grow from USD 65.89 billion in 2026 to USD 141.57 billion by 2034, registering a CAGR of 10.03% during the forecast period (2026-2034). North America dominated the market in 2025 with a 45.70% share, driven by strong healthcare expenditure, a high prevalence of female diseases, and growing demand for technologically advanced medical devices.

Rising awareness of female health issues, increased disposable incomes, and the growing prevalence of female cancers, such as breast and ovarian cancers, and other conditions like uterine fibroids are major factors driving market growth. Additionally, younger generations of women are increasingly adopting advanced health monitoring and diagnostic devices, boosting overall market expansion.

MARKET OVERVIEW

Recent developments in the women's health space have motivated companies to invest heavily in R&D and new product launches, ranging from diagnostic and monitoring devices to therapeutic equipment. For example, in December 2021, F. Hoffmann-La Roche Ltd launched the cobas PIK3CA Mutation Test for advanced or metastatic breast cancer, enhancing treatment precision and driving device adoption.

The COVID-19 pandemic temporarily hindered market growth due to limited hospital visits and disrupted supply chains. CooperSurgical Inc., for instance, reported an 11.2% revenue decline in 2020 in its fertility segment. However, by 2021, the market rebounded with 39.2% sales growth, aided by the increasing adoption of telemedicine and remote patient care solutions.

MARKET DRIVERS

Increasing Awareness of Women's Health Issues

Enhanced healthcare infrastructure, coupled with awareness campaigns by organizations like the U.S. FDA's Health of Women Program, has significantly increased women's adoption of health devices for early detection and preventive care. These initiatives have been particularly influential among younger women, leading to greater demand for diagnostic, therapeutic, and monitoring devices.

Rising Prevalence of Female Diseases

The growing prevalence of female cancers and chronic conditions such as cervical cancer, breast cancer, and uterine fibroids has escalated demand for specialized medical devices. According to WHO 2022, cervical cancer is the 4th most common cancer among women, with 604,000 new cases reported in 2020. Such trends are driving R&D initiatives and product launches, further propelling market growth.

RESTRAINING FACTORS

Limited awareness and low healthcare penetration in emerging regions restrict market growth. In countries like India and sub-Saharan Africa, cultural taboos, low diagnostic awareness, and limited access to advanced devices result in underutilization of women's health technologies, restraining overall market expansion.

SEGMENTATION

By Application

The cancers & other chronic diseases segment accounted for 34.74% of the market in 2026, due to high demand for effective diagnostic and therapeutic devices. The pregnancy & nursing care segment and reproductive health segment follow, driven by adoption of pregnancy diagnostics, breast pumps, and contraceptive devices. Pelvic and uterine healthcare devices, including urinary incontinence solutions, are also witnessing strong growth.

By End-User

Hospitals and clinics dominated the market in 2026 with a 59.42% share, due to patient influx for diagnostic and therapeutic treatments. Home healthcare is growing fastest, as patients increasingly prefer convenient at-home monitoring solutions. The "others" segment, which includes specialized clinics and telemedicine services, is growing steadily.

REGIONAL INSIGHTS

North America led the market with USD 27.60 billion in 2025, supported by strong government initiatives, technological adoption, and healthcare investments. Europe followed, with Germany and the U.K. expected to reach USD 4.48 billion and USD 2.85 billion by 2026, respectively, driven by high prevalence of female cancers and robust healthcare infrastructure.

Asia Pacific is projected to register the strongest CAGR due to increasing awareness, improved healthcare infrastructure, and approvals for advanced devices. Japan, China, and India are expected to reach USD 3.87 billion, USD 4.68 billion, and USD 2.2 billion by 2026, respectively. Emerging regions, including Latin America and the Middle East & Africa, are experiencing moderate growth due to improving healthcare access and increasing awareness.

KEY INDUSTRY PLAYERS

Prominent players include F. Hoffmann-La Roche Ltd., Boston Scientific Corporation, CooperSurgical Inc., Hologic Inc., Coloplast A/S, and ALLERGAN (AbbVie, Inc.). These companies are strengthening their portfolios through R&D, acquisitions, and strategic partnerships. For instance, CooperSurgical acquired Cook Medical's reproductive health portfolio for USD 875 million in 2022, expanding offerings in fertility, obstetrics, and gynecology devices.

CONCLUSION

The global women's health devices market is poised for robust growth from USD 60.39 billion in 2025 to USD 141.57 billion by 2034, driven by increasing prevalence of female diseases, awareness campaigns, technological advancements, and home healthcare adoption. Despite challenges in emerging markets, strategic investments, R&D innovations, and government initiatives are expected to sustain market expansion, making the sector highly attractive for global players and new entrants alike.

Segmentation By Application, End-user, and Region

By Application * General Health & Wellness

  • Cancers & Other Chronic Diseases
  • Reproductive Health
  • Pregnancy & Nursing Care
  • Pelvic & Uterine Healthcare
  • Others

By End-user * Hospitals & Clinics

  • Home Healthcare
  • Others

By Region * North America (By Application, By End-user, and By Country)

    • U.S.
    • Canada
  • Europe (By Application, By End-user, and By Country/Sub-Region)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific (By Application, By End-user, and By Country/Sub-Region)
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia Pacific
  • Rest of the World (By Application and By End-user)

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Prevalence of Key Disease Indications, By Key Countries/ Regions, 2025
  • 4.2. Overview: Start-ups and Innovations in the Women's Health Devices Market
  • 4.3. Key Industry Developments - Mergers, Acquisitions, and Partnerships
  • 4.4. Impact of COVID-19 on the Women's Health Devices Market

5. Global Women's Health Devices Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Application
    • 5.1.1. General Health & Wellness
    • 5.1.2. Cancers & Other Chronic Diseases
    • 5.1.3. Reproductive Health
    • 5.1.4. Pregnancy & Nursing Care
    • 5.1.5. Pelvic & Uterine Healthcare
    • 5.1.6. Others
  • 5.2. Market Analysis, Insights and Forecast - By End User
    • 5.2.1. Hospitals & Clinics
    • 5.2.2. Home Healthcare
    • 5.2.3. Others
  • 5.3. Market Analysis, Insights and Forecast - By Region
    • 5.3.1. North America
    • 5.3.2. Europe
    • 5.3.3. Asia Pacific
    • 5.3.4. Rest of the World

6. North America Women's Health Devices Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Application
    • 6.1.1. General Health & Wellness
    • 6.1.2. Cancers & Other Chronic Diseases
    • 6.1.3. Reproductive Health
    • 6.1.4. Pregnancy & Nursing Care
    • 6.1.5. Pelvic & Uterine Healthcare
    • 6.1.6. Others
  • 6.2. Market Analysis, Insights and Forecast- By End User
    • 6.2.1. Hospitals & Clinics
    • 6.2.2. Home Healthcare
    • 6.2.3. Others
  • 6.3. Market Analysis, Insights and Forecast - By Country
    • 6.3.1. U.S.
    • 6.3.2. Canada

7. Europe Women's Health Devices Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast- By Application
    • 7.1.1. General Health & Wellness
    • 7.1.2. Cancers & Other Chronic Diseases
    • 7.1.3. Reproductive Health
    • 7.1.4. Pregnancy & Nursing Care
    • 7.1.5. Pelvic & Uterine Healthcare
    • 7.1.6. Others
  • 7.2. Market Analysis, Insights and Forecast- By End User
    • 7.2.1. Hospitals & Clinics
    • 7.2.2. Home Healthcare
    • 7.2.3. Others
  • 7.3. Market Analysis, Insights and Forecast- By Country/ Sub-Region
    • 7.3.1. U.K.
    • 7.3.2. Germany
    • 7.3.3. France
    • 7.3.4. Spain
    • 7.3.5. Italy
    • 7.3.6. Rest of Europe

8. Asia Pacific Women's Health Devices Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast- By Application
    • 8.1.1. General Health & Wellness
    • 8.1.2. Cancers & Other Chronic Diseases
    • 8.1.3. Reproductive Health
    • 8.1.4. Pregnancy & Nursing Care
    • 8.1.5. Pelvic & Uterine Healthcare
    • 8.1.6. Others
  • 8.2. Market Analysis, Insights and Forecast- By End User
    • 8.2.1. Hospitals & Clinics
    • 8.2.2. Home Healthcare
    • 8.2.3. Others
  • 8.3. Market Analysis, Insights and Forecast- By Country/ Sub-Region
    • 8.3.1. Japan
    • 8.3.2. China
    • 8.3.3. India
    • 8.3.4. Australia
    • 8.3.5. Rest of Asia Pacific

9. Rest of World Women's Health Devices Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast- By Application
    • 9.1.1. General Health & Wellness
    • 9.1.2. Cancers & Other Chronic Diseases
    • 9.1.3. Reproductive Health
    • 9.1.4. Pregnancy & Nursing Care
    • 9.1.5. Pelvic & Uterine Healthcare
    • 9.1.6. Others
  • 9.2. Market Analysis, Insights and Forecast- By End User
    • 9.2.1. Hospitals & Clinics
    • 9.2.2. Home Healthcare
    • 9.2.3. Others

10. Competitive Analysis

  • 10.1. Global Market Share Analysis (2025)
  • 10.2. Company Profiles (Overview, Products, SWOT Analysis, Recent Developments, Strategies, Financials (Based On Availability))
    • 10.2.1. Coloplast A/S
      • 10.2.1.1. Overview,
      • 10.2.1.2. Products,
      • 10.2.1.3. SWOT Analysis,
      • 10.2.1.4. Recent Developments,
      • 10.2.1.5. Strategies,
      • 10.2.1.6. Financials (Based On Availability)
    • 10.2.2. Hologic, Inc.
      • 10.2.2.1. Overview,
      • 10.2.2.2. Products,
      • 10.2.2.3. SWOT Analysis,
      • 10.2.2.4. Recent Developments,
      • 10.2.2.5. Strategies,
      • 10.2.2.6. Financials (Based On Availability)
    • 10.2.3. Boston Scientific Corporation
      • 10.2.3.1. Overview,
      • 10.2.3.2. Products,
      • 10.2.3.3. SWOT Analysis,
      • 10.2.3.4. Recent Developments,
      • 10.2.3.5. Strategies,
      • 10.2.3.6. Financials (Based On Availability)
    • 10.2.4. ALLERGAN (AbbVie, Inc.)
      • 10.2.4.1. Overview,
      • 10.2.4.2. Products,
      • 10.2.4.3. SWOT Analysis,
      • 10.2.4.4. Recent Developments,
      • 10.2.4.5. Strategies,
      • 10.2.4.6. Financials (Based On Availability)
    • 10.2.5. BD (Becton, Dickinson and Company)
      • 10.2.5.1. Overview,
      • 10.2.5.2. Products,
      • 10.2.5.3. SWOT Analysis,
      • 10.2.5.4. Recent Developments,
      • 10.2.5.5. Strategies,
      • 10.2.5.6. Financials (Based On Availability)
    • 10.2.6. F. Hoffmann-La Roche Ltd
      • 10.2.6.1. Overview,
      • 10.2.6.2. Products,
      • 10.2.6.3. SWOT Analysis,
      • 10.2.6.4. Recent Developments,
      • 10.2.6.5. Strategies,
      • 10.2.6.6. Financials (Based On Availability)
    • 10.2.7. CooperSurgical Inc. (The Cooper Companies, Inc.)
      • 10.2.7.1. Overview,
      • 10.2.7.2. Products,
      • 10.2.7.3. SWOT Analysis,
      • 10.2.7.4. Recent Developments,
      • 10.2.7.5. Strategies,
      • 10.2.7.6. Financials (Based On Availability)
    • 10.2.8. Caldera Medical
      • 10.2.8.1. Overview,
      • 10.2.8.2. Products,
      • 10.2.8.3. SWOT Analysis,
      • 10.2.8.4. Recent Developments,
      • 10.2.8.5. Strategies,
      • 10.2.8.6. Financials (Based On Availability)
    • 10.2.9. Reckitt Benckiser Group PLC
      • 10.2.9.1. Overview,
      • 10.2.9.2. Products,
      • 10.2.9.3. SWOT Analysis,
      • 10.2.9.4. Recent Developments,
      • 10.2.9.5. Strategies,
      • 10.2.9.6. Financials (Based On Availability)

List of Tables

  • Table 01: Global Women's Health Devices Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 02: Global Women's Health Devices Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 03: Global Women's Health Devices Market Revenue (USD billion) Forecast, by Region, 2021-2034
  • Table 04: North America Women's Health Devices Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 05: North America Women's Health Devices Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 06: North America Women's Health Devices Market Revenue (USD billion) Forecast, by Country, 2021-2034
  • Table 07: Europe Women's Health Devices Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 08: Europe Women's Health Devices Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 09: Europe Women's Health Devices Market Revenue (USD billion) Forecast, by Country/Sub-Region, 2021-2034
  • Table 10: Asia Pacific Women's Health Devices Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 11: Asia Pacific Women's Health Devices Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 12: Asia Pacific Women's Health Devices Market Revenue (USD billion) Forecast, by Country/Sub-Region, 2021-2034
  • Table 13: Rest of World Women's Health Devices Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 14: Rest of World Women's Health Devices Market Revenue (USD billion) Forecast, by End User, 2021-2034

List of Figures

  • Figure 01: Global Women's Health Devices Market Value Share (%), by Application, 2025 & 2034
  • Figure 02: Global Women's Health Devices Market Value Share (%), by End User, 2025 & 2034
  • Figure 03: Global Women's Health Devices Market Value Share (%), by Region, 2025 & 2034
  • Figure 04: North America Women's Health Devices Market Value (USD billion), by Application, 2025 & 2034
  • Figure 05: North America Women's Health Devices Market Value Share (%), by Application, 2025
  • Figure 06: North America Women's Health Devices Market Value (USD billion), by End User, 2025 & 2034
  • Figure 07: North America Women's Health Devices Market Value Share (%), by End User, 2025
  • Figure 08: North America Women's Health Devices Market Value (USD billion), by Country, 2025 & 2034
  • Figure 09: North America Women's Health Devices Market Value Share (%), by Country, 2025
  • Figure 10: Europe Women's Health Devices Market Value (USD billion), by Application, 2025 & 2034
  • Figure 11: Europe Women's Health Devices Market Value Share (%), by Application, 2025
  • Figure 12: Europe Women's Health Devices Market Value (USD billion), by End User, 2025 & 2034
  • Figure 13: Europe Women's Health Devices Market Value Share (%), by End User, 2025
  • Figure 14: Europe Women's Health Devices Market Value (USD billion), by Country/Sub-Region, 2025 & 2034
  • Figure 15: Europe Women's Health Devices Market Value Share (%), by Country/Sub-Region, 2025
  • Figure 16: Asia Pacific Women's Health Devices Market Value (USD billion), by Application, 2025 & 2034
  • Figure 17: Asia Pacific Women's Health Devices Market Value Share (%), by Application, 2025
  • Figure 18: Asia Pacific Women's Health Devices Market Value (USD billion), by End User, 2025 & 2034
  • Figure 19: Asia Pacific Women's Health Devices Market Value Share (%), by End User, 2025
  • Figure 20: Asia Pacific Women's Health Devices Market Value (USD billion), by Country/Sub-Region, 2025 & 2034
  • Figure 21: Asia Pacific Women's Health Devices Market Value Share (%), by Country/Sub-Region, 2025
  • Figure 22: Rest of World Women's Health Devices Market Value (USD billion), by Application, 2025 & 2034
  • Figure 23: Rest of World Women's Health Devices Market Value Share (%), by Application, 2025
  • Figure 24: Rest of World Women's Health Devices Market Value (USD billion), by End User, 2025 & 2034
  • Figure 25: Rest of World Women's Health Devices Market Value Share (%), by End User, 2025
  • Figure 26: Global Women's Health Devices Market Share Analysis, By Company, 2025